These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35908744)

  • 1. Loss of mitochondrial enzyme GPT2 causes early neurodegeneration in locus coeruleus.
    Baytas O; Kauer JA; Morrow EM
    Neurobiol Dis; 2022 Oct; 173():105831. PubMed ID: 35908744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial enzyme GPT2 regulates metabolic mechanisms required for neuron growth and motor function in vivo.
    Baytas O; Davidson SM; DeBerardinis RJ; Morrow EM
    Hum Mol Genet; 2022 Feb; 31(4):587-603. PubMed ID: 34519342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice.
    O'Neil JN; Mouton PR; Tizabi Y; Ottinger MA; Lei DL; Ingram DK; Manaye KF
    J Chem Neuroanat; 2007 Nov; 34(3-4):102-7. PubMed ID: 17658239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
    Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
    Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
    Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features.
    Ouyang Q; Nakayama T; Baytas O; Davidson SM; Yang C; Schmidt M; Lizarraga SB; Mishra S; Ei-Quessny M; Niaz S; Gul Butt M; Imran Murtaza S; Javed A; Chaudhry HR; Vaughan DJ; Hill RS; Partlow JN; Yoo SY; Lam AT; Nasir R; Al-Saffar M; Barkovich AJ; Schwede M; Nagpal S; Rajab A; DeBerardinis RJ; Housman DE; Mochida GH; Morrow EM
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5598-607. PubMed ID: 27601654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
    Feinstein DL; Kalinin S; Braun D
    J Neurochem; 2016 Oct; 139 Suppl 2():154-178. PubMed ID: 26968403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
    Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
    J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration.
    Wang Q; Oyarzabal EA; Song S; Wilson B; Santos JH; Hong JS
    Brain Behav Immun; 2020 Jul; 87():359-368. PubMed ID: 31923552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic changes of locus coeruleus damage in Parkinson's disease-like mice induced by paraquat].
    Zhang BY; Wang KD; Zhang BF; Tian T; Wang YF; Huang M
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Apr; 40(4):260-266. PubMed ID: 35545591
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice.
    Roux JC; Panayotis N; Dura E; Villard L
    J Neurosci Res; 2010 May; 88(7):1500-9. PubMed ID: 19998492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
    Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice.
    Szot P; Van Dam D; White SS; Franklin A; Staufenbiel M; De Deyn PP
    Neurosci Lett; 2009 Sep; 463(1):93-7. PubMed ID: 19631722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.
    Matchett BJ; Grinberg LT; Theofilas P; Murray ME
    Acta Neuropathol; 2021 May; 141(5):631-650. PubMed ID: 33427939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.